FACTOR XIII (FIBRIN STABILISING FACTOR) IN HENOCH‐SCHÖNLEIN'S PURPURA

Abstract
In 13 of 17 consecutive children with Henoch-Schoenlein''s purpura the factor XIII determined with the dansyl cadaverine method was decreased during the acute phase. The decrease was assumed to be due to a specific degradation by proteolytic enzymes liberated from inflammatory cells, with defective local hemostasis as a result. Treatment with factor XIII combined with an antifibrinolytic drug controlled life-threatening gastrointestinal bleeding in 1 of the patients. Such treatment might offer a new possibility of controlling severe hemorrhages in Henoch-Schoenlein''s purpura.